V007-2691 Screening compound: 2-{[(1-phenylethyl)({[2-(trifluoromethyl)phenyl]methyl})amino]methyl}-N-[(pyridin-4-yl)methyl]-1,3-oxazole-4-carboxamide

V007-2691 Screening compound: 2-{[(1-phenylethyl)({[2-(trifluoromethyl)phenyl]methyl})amino]methyl}-N-[(pyridin-4-yl)methyl]-1,3-oxazole-4-carboxamide
V007-2691 Screening compound: 2-{[(1-phenylethyl)({[2-(trifluoromethyl)phenyl]methyl})amino]methyl}-N-[(pyridin-4-yl)methyl]-1,3-oxazole-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V007-2691
2-{[(1-phenylethyl)({[2-(trifluoromethyl)phenyl]methyl})amino]methyl}-N-[(pyridin-4-yl)methyl]-1,3-oxazole-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V007-2691

Molecular Formula

C27H25F3N4O2 (C27 H25 F3 N4 O2)

Compound Name

2-{[(1-phenylethyl)({[2-(trifluoromethyl)phenyl]methyl})amino]methyl}-N-[(pyridin-4-yl)methyl]-1,3-oxazole-4-carboxamide

IUPAC name

2-{[(1-phenylethyl)({[2-(trifluoromethyl)phenyl]methyl})amino]methyl}-N-[(pyridin-4-yl)methyl]-13-oxazole-4-carboxamide

SMILES

CC(c1ccccc1)N(Cc1nc(C(NCc2ccncc2)=O)co1)Cc1c(C(F)(F)F)cccc1

InChI

InChI=1S/C27H25F3N4O2/c1-19(21-7-3-2-4-8-21)34(16-22-9-5-6-10-23(22)27(28,29)30)17-25-33-24(18-36-25)26(35)32-15-20-11-13-31-14-12-20/h2-14,18-19H,15-17H2,1H3,(H,32,35)/t19-/m0/s1

InChI Key

UZVZQMCZGCCITR-IBGZPJMESA-N

MDL Number (MFCD)

MFCD19832046

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

494.52

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.391

Distribution Coefficient, logD

4.388

Water Solubility, LogSw

-4.25

Polar Surface Area

55.182

Acid Dissociation Constant (pKa)

12.92

Base Dissociation Constant (pKb)

5.29

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

22.20

V007-2691 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
Targets:
  • GPCR
  • Ion Channels

References: we are preparing a list of scientific research reports with V007-2691 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V007-2691?
Check Price and Availability of V007-2691, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V007-2691 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V007-2691
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V007-2691
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V007-2691 available by request